About Innostem Bio
Pioneering the future of regenerative medicine through groundbreaking stem cell research and technology.
Mission & Vision
Our platform is built on four pillars of technological excellence, setting a new standard in regenerative medicine.
Unique allogeneic stem cell therapy derived from heart and peripheral nerve in Korea and a world first.
A pharmaceutical-grade cell bank platform for industrial-scale production.
High-density culture, tissue engineering, and ready-to-inject formulations.
Developing novel therapies for rare and intractable conditions like spinal cord/brain injury, critical limb ischemia and muscular dystrophy.
Management Team
Guided by visionaries with decades of pioneering research and financial expertise in regenerative medicine.
Dr. Youngil Yang, M.D., Ph.D.
Chief Executive Officer & Chief Technology Officer
Dr. Young-Il Yang is a physician-scientist with over 20 years of research experience in stem cell biology, tissue engineering, and regenerative medicine. He has led the development of numerous core technologies and platforms, and is currently dedicated to advancing innovative bio solutions. By integrating medicine and science, he is at the forefront of commercializing next-generation therapeutic technologies.
Jae Young Seo
Chief Financial Officer
Jae-Young Seo brings extensive experience in accounting and finance, leading financial management and corporate growth. With a strong background from firms such as Samdo Accounting Corporation, IBK Industrial Bank of Korea, and Deloitte, he is responsible for ensuring Innostem Bio’s financial stability and sustainable development.
Choong Hyun Kang
Strategic Development Advisor
Choong-Hyun Kang is a proven expert in business strategy, with a track record of discovering and nurturing numerous startups as both a private equity fund manager and angel investor—successfully guiding them to IPO. As the current CEO of Four Company, he plays a key role in corporate growth and strategic planning.
Research Team
Meet the dedicated scientists and researchers driving our innovation.
Wonjin Lee, M.D., Ph.D.
Clinical Development Manager
Dr. Won-Jin Lee is a board-certified anesthesiologist with rich clinical experience and academic depth. He leads the expansion of clinical indications and clinical research strategies, contributing to the design and execution of innovative clinical trials through his combined medical expertise and research capabilities.
Hye Ran Kim
Senior Researcher, Manufacturing Development Team
Hye-Ran Kim is an expert in chemical and biological analysis and is developing manufacturing processes for stem cell therapies and extracellular vesicles. She contributes to securing process reliability through quality-based process exploration and validation.
Ye Yeon Jin
Senior Researcher, Quality Control Team
Ye-Yeon Jin specializes in quality assessment and develops systematic analysis methods based on regulatory guidelines. With a background in biotechnology, she contributes to improving product safety and quality.
Na Eun Won
Team Leader, Quality Assurance
Na-Eun Won is a quality assurance specialist with extensive experience in pharmaceutical and medical device regulatory affairs and GMP/FDA documentation. She ensures product safety and efficacy through reliable quality management.